CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on […]
BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
SUNNYVALE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics […]
Cellebrite Announces “Redemption Fair Market Value” in Connection with Redemption of All Outstanding Warrants
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the […]
HOOKIPA Pharma Announces Board of Directors Changes
NEW YORK and VIENNA, Aug. 30, 2024 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK) (“HOOKIPA” or the “Company”), a […]
DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence
NORWELL, Mass. and HAAPSALU, Estonia, Aug. 30, 2024 (GLOBE NEWSWIRE) — DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of […]
Gentex Announces Third Quarter 2024 Cash Dividend
ZEELAND, Mich., Aug. 30, 2024 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected […]
Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q
New York, NY, Aug. 30, 2024 (GLOBE NEWSWIRE) — Qomolangma Acquisition Corp. (Nasdaq: QOMO) (the “Company”) announced that it has […]
Ventyx Biosciences Announces Departure of Chief Financial Officer
SAN DIEGO, Aug. 30, 2024 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on […]
Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
STOUGHTON, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to […]
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced […]
